Our services

Viral Vector Manufacturing Services

3PBIOVIAN provides fully integrated viral vector manufacturing services supporting gene therapy, vaccine, and advanced therapeutic development. With state-of-the-art facilities and a highly experienced team, we offer end-to-end viral vector production — from process design and optimization to GMP manufacturing and quality control. Our mission is to accelerate your path from concept to clinic with speed, safety, and reliability.

Always close, we are with you all the way on your Viral Vector Manufacturing journey. Together, making advanced biologics, and tomorrow’s life-transforming therapies.

This is affinity in the making.

Always close, we are with you all the way on your Viral Vector Manufacturing journey // 3PBIOVIAN / Affinity in the making.

Rely on our comprehensive viral vector process development and GMP production of AAV and adenovirus vectors to accelerate your projects seamlessly.

Our process development services support the Quality by Design (QbD) approach from the earliest stage, enabling a smooth transition to GMP production.

  • Research Cell Bank
  • Master Cell Bank and Working Cell Bank
  • Master Viral Seed Stock and Working Seed Stock
  • Suspension cell culture in single-use bioreactors – up to 200 L
  • Adherent cell culture in multilayer flasks, packed-bed bioreactor and single-use bioreactors on microcarriers
  • Ultracentrifugation-based Downstream Processes
  • Chromatography-based Downstream Processes
  • Comprehensive purification solutions:
    • Affinity Chromatography
    • Anion Exchange Chromatography (AEX)
    • Cation Exchange Chromatography (CEX)
    • Tangential Flow Filtration (TFF)
    • Cesium Chloride Gradient

  • Formulation and final Drug Product manufacturing
  • Automated aseptic filling line for live viral vectors
  • Typical batch sizes 200 – 1000 vials
  • Product-specific assays
  • Impurity analysis
  • Cell-based assays
  • Microbiological QC and safety assays (sterility, bioburden, endotoxin etc.)
  • QP certification and full GMP documentation

As a trusted provider of viral vectors, 3PBIOVIAN enables gene therapy developers to scale from research to commercial supply. We manufacture AAV and adenovirus vectors under rigorous GMP conditions, ensuring genetic integrity, potency, and purity. Every process is optimized for consistency and regulatory compliance, supporting even the most advanced gene therapy platforms.

3PBIOVIAN delivers viral vector CDMO solutions tailored to your stage of development — from preclinical studies to commercial manufacturing. Our multidisciplinary teams combine process development, analytical expertise, and GMP manufacturing capabilities, offering a seamless CDMO partnership that ensures reliability, scalability, and timely delivery across global markets.

Among the leading viral vector manufacturing companies, 3PBIOVIAN stands out for its proven GMP expertise and end-to-end project management. Our facilities operate under strict regulatory oversight, ensuring full traceability, batch documentation, and compliance with EMA and FDA guidelines. Clients worldwide trust our team to deliver safe, reproducible viral vector products ready for clinical and commercial use.


AAV Manufacturing

We provide reliable AAV vectors certified for clinical use with full GMP documentation and support from Qualified Persons.

Learn more >

Adenovirus Manufacturing

Experience our seamless adenovirus manufacturing solutions for adherent or suspension cell cultures, ensuring successful scalability and GMP compliance. We have a track record two decades in adenovirus GMP manufacturing

Learn more >

Scalability and quality are built into every viral vector project we deliver. 3PBIOVIAN’s modular cleanroom suites, advanced bioreactor systems, and closed-system production technologies enable smooth transition from small pilot runs to commercial scale. Each process is optimized to maximize vector yield while maintaining product consistency and potency.

Our viral vector production workflows are fully aligned with international GMP guidelines. We ensure every step — from plasmid preparation and cell banking to purification and fill-finish — is validated and documented according to regulatory expectations. With 3PBIOVIAN, your gene therapy vectors are produced under the highest quality and safety standards.

Every gene therapy program is unique. That’s why 3PBIOVIAN’s viral vector services are fully customizable — whether you require upstream process development, technology transfer, analytical validation, or large-scale GMP manufacturing. Our flexible CDMO model adapts to your specific goals, timelines, and regulatory path.

Production of Viral Vectors with High Yield and Batch Consistency

Trusted Viral Vector Manufacturing Companies Supporting Global Biotech

We implement advanced process control strategies to achieve high viral titers and batch-to-batch consistency. Through optimized transfection, scalable purification, and in-process analytics, our GMP viral vector production platforms deliver superior yield and reproducibility across multiple vector types.

3PBIOVIAN collaborates with biotechnology companies worldwide, providing viral vector manufacturing expertise that bridges innovation and compliance. Our proven track record in GMP production, scalability, and regulatory readiness positions us as a long-term CDMO partner for global biotherapeutic success.

With you all the way…

together, making advanced biologics, and tomorrow’s life-transforming therapies.

We deliver unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substances and Drug Products, from pre-clinical to clinical development and commercial phases.

We support our customers wherever they are on their journey, from early-stage development to commercialization. We are passionate, precise, and always close, together, making advanced biologics and tomorrow’s life-transforming therapies.


Pre-Clinical

Phase I

Phase II

Phase III

Commercial